Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-[[(4-Fluorophenyl)imino]methyl]-phenol is a pale yellow solid with a unique chemical structure that features a phenol group and an imino linkage to a fluorophenyl group. 4-[[(4-Fluorophenyl)imino]methyl]-phenol is known for its potential applications in various industries, particularly in the synthesis of compounds with biological activities.

3382-63-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 3382-63-6 Structure
  • Basic information

    1. Product Name: 4-[[(4-Fluorophenyl)imino]methyl]-phenol
    2. Synonyms: 4-(4-HYDROXYBENZYLIDENE) FLUORO ANILINE;4-(((4-FLUOROPHENYL)IMINO)METHYL)PHENOL;2-(4 ' -Hydrophenyl)-4-fluorobenyl imine;alpha-4-Fluorophenylimino-p-cresol;(E)-4-((4-Fluorophenylimino)methyl)phenol;4-fluoro-N-(hydroxyphenyl)methylene-benzenamine;E2:4{[(4-fluorophenyl)imino]methyl}phenol;Phenol, 4-[[(4-fluorophenyl)iMino]Methyl]-
    3. CAS NO:3382-63-6
    4. Molecular Formula: C13H10FNO
    5. Molecular Weight: 215.22
    6. EINECS: 1308068-626-2
    7. Product Categories: Intermediate of ezetimibe;Ezetimibe INTERMEDIATES
    8. Mol File: 3382-63-6.mol
  • Chemical Properties

    1. Melting Point: 179.0 to 183.0 °C
    2. Boiling Point: 370.9 °C at 760 mmHg
    3. Flash Point: 178.1 °C
    4. Appearance: /
    5. Density: 1.13 g/cm3
    6. Vapor Pressure: 0mmHg at 25°C
    7. Refractive Index: 1.558
    8. Storage Temp.: Sealed in dry,Room Temperature
    9. Solubility: DMSO (Slightly), Methanol (Slightly)
    10. PKA: 8.56±0.15(Predicted)
    11. CAS DataBase Reference: 4-[[(4-Fluorophenyl)imino]methyl]-phenol(CAS DataBase Reference)
    12. NIST Chemistry Reference: 4-[[(4-Fluorophenyl)imino]methyl]-phenol(3382-63-6)
    13. EPA Substance Registry System: 4-[[(4-Fluorophenyl)imino]methyl]-phenol(3382-63-6)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 3382-63-6(Hazardous Substances Data)

3382-63-6 Usage

Uses

Used in Pharmaceutical Industry:
4-[[(4-Fluorophenyl)imino]methyl]-phenol is used as an intermediate in the synthesis of benzylacetones, which are known to promote anti-fungal activity. This application is significant in the development of new anti-fungal drugs to combat various fungal infections.
Used in Chemical Synthesis:
As a pale yellow solid with specific chemical properties, 4-[[(4-Fluorophenyl)imino]methyl]-phenol can be utilized in the synthesis of other organic compounds, potentially leading to the creation of new materials or pharmaceuticals with various applications.

Check Digit Verification of cas no

The CAS Registry Mumber 3382-63-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,3,8 and 2 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 3382-63:
(6*3)+(5*3)+(4*8)+(3*2)+(2*6)+(1*3)=86
86 % 10 = 6
So 3382-63-6 is a valid CAS Registry Number.
InChI:InChI=1/C13H10FNO/c14-11-3-5-12(6-4-11)15-9-10-1-7-13(16)8-2-10/h1-9,16H/b15-9+

3382-63-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-[(4-fluoroanilino)methylidene]cyclohexa-2,5-dien-1-one

1.2 Other means of identification

Product number -
Other names 4-[[(p-Fluorophenyl)imino]methyl]phenol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3382-63-6 SDS

3382-63-6Synthetic route

4-hydroxy-benzaldehyde
123-08-0

4-hydroxy-benzaldehyde

4-fluoroaniline
371-40-4

4-fluoroaniline

N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

Conditions
ConditionsYield
In water at 20 - 85℃; for 5.5h; Large scale;97.5%
In methanol at 20 - 30℃; Large scale;90%
In isopropyl alcohol at 50℃; for 1h;88%
ezetemibe
163222-33-1

ezetemibe

A

(-)-6-(4-fluorophenyl)tetrahydro-2H-pyran-2-one
793673-93-5

(-)-6-(4-fluorophenyl)tetrahydro-2H-pyran-2-one

B

N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

Conditions
ConditionsYield
In water; acetonitrile UV-irradiation;
p-azidofluorobenzene
3296-02-4

p-azidofluorobenzene

trans-4-Hydroxystilbene
6554-98-9

trans-4-Hydroxystilbene

A

N-benzylidene-4-fluoroaniline
331-98-6, 83306-62-1, 83306-65-4

N-benzylidene-4-fluoroaniline

B

N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

Conditions
ConditionsYield
With iron(II) chloride In acetonitrile at 100℃; Sealed tube; Inert atmosphere;
4-fluoroaniline
371-40-4

4-fluoroaniline

A

N-benzylidene-4-fluoroaniline
331-98-6, 83306-62-1, 83306-65-4

N-benzylidene-4-fluoroaniline

B

N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: hydrogenchloride; sodium nitrite / water / 1 h / 0 - 5 °C / Inert atmosphere
1.2: 10 h / 20 °C / Inert atmosphere
2.1: iron(II) chloride / acetonitrile / 100 °C / Sealed tube; Inert atmosphere
View Scheme
4-hydroxybenzenediazonium tetrafluoroborate

4-hydroxybenzenediazonium tetrafluoroborate

N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium acetate; palladium diacetate / 12 h / 20 °C / Inert atmosphere
2: iron(II) chloride / acetonitrile / 100 °C / Sealed tube; Inert atmosphere
View Scheme
N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

N-(4-((tert-butyldimethylsilyl)oxy)benzylidene)-4-fluoroaniline
179411-51-9

N-(4-((tert-butyldimethylsilyl)oxy)benzylidene)-4-fluoroaniline

Conditions
ConditionsYield
Stage #1: N-(4-hydroxybenzylidene)-4-fluorobenzenamine With dmap; triethylamine In dichloromethane at 0℃; for 0.166667h; Inert atmosphere;
Stage #2: tert-butyldimethylsilyl chloride In dichloromethane at 0 - 20℃; Inert atmosphere;
99%
With 1H-imidazole In N,N-dimethyl-formamide at 60℃; for 4h;97.5%
N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

acetyl chloride
75-36-5

acetyl chloride

C15H12FNO2

C15H12FNO2

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; for 5h;98%
N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

trityl chloride
76-83-5

trityl chloride

N-(4-trityloxybenzylidene)-4-fluoroaniline
1159183-26-2

N-(4-trityloxybenzylidene)-4-fluoroaniline

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 10 - 20℃; for 1.08333h;97.8%
With N-ethyl-N,N-diisopropylamine In dichloromethane at 10 - 20℃;
With N-ethyl-N,N-diisopropylamine In dichloromethane at 10 - 20℃;
chloro-trimethyl-silane
75-77-4

chloro-trimethyl-silane

3-[5-(4-fluorophenyl)-1,5-dioxopentyl]-4-phenyl-2-oxazolidinone
1076200-08-2

3-[5-(4-fluorophenyl)-1,5-dioxopentyl]-4-phenyl-2-oxazolidinone

N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

3-{2-[3-(fluorophenyl)-3-(trimethyl silyloxy)-propyl]-3-(4-fluoro phenyl amino)-3-(4-trimethyl silyloxy phenyl)-1-oxo-propyl}-4-(S)-phenyl oxazolidin-2-one
858126-22-4

3-{2-[3-(fluorophenyl)-3-(trimethyl silyloxy)-propyl]-3-(4-fluoro phenyl amino)-3-(4-trimethyl silyloxy phenyl)-1-oxo-propyl}-4-(S)-phenyl oxazolidin-2-one

Conditions
ConditionsYield
Stage #1: 3-[5-(4-fluorophenyl)-1,5-dioxopentyl]-4-phenyl-2-oxazolidinone With dimethylsulfide borane complex; ascorbic acid; (3aR)-1-methyl-3,3-diphenyl-tetrahydro-pyrrolo[1,2-c][1,3,2]oxazaborole In dichloromethane at -10 - 8℃; for 7.25h; Inert atmosphere; Large scale;
Stage #2: With dihydrogen peroxide In methanol; dichloromethane at -5 - 20℃; for 0.5h; Inert atmosphere; Large scale;
Stage #3: chloro-trimethyl-silane; N-(4-hydroxybenzylidene)-4-fluorobenzenamine Large scale; Further stages;
96.3%
N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

2,2,2-Trichloroethyl chloroformate
17341-93-4

2,2,2-Trichloroethyl chloroformate

C16H11Cl3FNO3

C16H11Cl3FNO3

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 5℃; for 6h;95%
N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

pivaloyl chloride
3282-30-2

pivaloyl chloride

2,2-dimethylpropionic acid 4-[(4-fluorophenylimino)methyl]phenyl ester
1232148-23-0

2,2-dimethylpropionic acid 4-[(4-fluorophenylimino)methyl]phenyl ester

Conditions
ConditionsYield
With triethylamine In dichloromethane93%
chloro-trimethyl-silane
75-77-4

chloro-trimethyl-silane

methyl 5S-5-(4-fluorophenyl)-5-hydroxyvalerate
870634-36-9

methyl 5S-5-(4-fluorophenyl)-5-hydroxyvalerate

N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

(3R,4S)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-(trimethylsilyloxy)propanyl)-4-(4-(trimethylsiloxy)phenyl)azetidinone

(3R,4S)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-(trimethylsilyloxy)propanyl)-4-(4-(trimethylsiloxy)phenyl)azetidinone

Conditions
ConditionsYield
Stage #1: chloro-trimethyl-silane; methyl 5S-5-(4-fluorophenyl)-5-hydroxyvalerate; N-(4-hydroxybenzylidene)-4-fluorobenzenamine With N-ethyl-N,N-diisopropylamine In tetrahydrofuran at -10 - 0℃; Inert atmosphere;
Stage #2: With (R,R)-(+)-N-benzyl-3,4-bis(diphenylphosphino)pyrrolidine; lithium diisopropyl amide In tetrahydrofuran; n-heptane; ethylbenzene at -10 - 0℃; Inert atmosphere;
79%
methyl 5S-5-(4-fluorophenyl)-5-hydroxyvalerate
870634-36-9

methyl 5S-5-(4-fluorophenyl)-5-hydroxyvalerate

triethylsilyl chloride
994-30-9

triethylsilyl chloride

N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

C36H49F2NO3Si2

C36H49F2NO3Si2

Conditions
ConditionsYield
Stage #1: methyl 5S-5-(4-fluorophenyl)-5-hydroxyvalerate; triethylsilyl chloride; N-(4-hydroxybenzylidene)-4-fluorobenzenamine With tributyl-amine In 2-methyltetrahydrofuran at -10 - 0℃; Inert atmosphere;
Stage #2: With (R,R)-(+)-N-benzyl-3,4-bis(diphenylphosphino)pyrrolidine; lithium diisopropyl amide In tetrahydrofuran; n-heptane; ethylbenzene at -10 - 0℃; Inert atmosphere;
78.3%
methyl 5S-5-(4-fluorophenyl)-5-hydroxyvalerate
870634-36-9

methyl 5S-5-(4-fluorophenyl)-5-hydroxyvalerate

chlorotripropylsilane
995-25-5

chlorotripropylsilane

N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

C42H61F2NO3Si2

C42H61F2NO3Si2

Conditions
ConditionsYield
Stage #1: methyl 5S-5-(4-fluorophenyl)-5-hydroxyvalerate; chlorotripropylsilane; N-(4-hydroxybenzylidene)-4-fluorobenzenamine With triethylamine In 2-methyltetrahydrofuran at -20 - -10℃; Inert atmosphere;
Stage #2: With (R,R)-(+)-N-benzyl-3,4-bis(diphenylphosphino)pyrrolidine; lithium diisopropyl amide In tetrahydrofuran; n-heptane; ethylbenzene at -20 - -10℃; Inert atmosphere;
76.7%
chloro-trimethyl-silane
75-77-4

chloro-trimethyl-silane

N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

C20H19ClFNO4

C20H19ClFNO4

C39H45ClF2N2O5Si2

C39H45ClF2N2O5Si2

Conditions
ConditionsYield
Stage #1: chloro-trimethyl-silane; N-(4-hydroxybenzylidene)-4-fluorobenzenamine; C20H19ClFNO4 With N-ethyl-N,N-diisopropylamine for 1h;
Stage #2: With titanium tetrachloride at -30 - -25℃; for 3h;
71%
chloro-trimethyl-silane
75-77-4

chloro-trimethyl-silane

N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

(4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidine-2-one
189028-95-3

(4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidine-2-one

(4S)-3-[(2R,5S)-5-(4-fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino]({4-[(trimethylsilyl)oxy]phenyl})methyl]-5-[(trimethylsilyl)oxy]pentanoyl]-4-phenyl-1,3-oxazolidin-2-one
272778-12-8

(4S)-3-[(2R,5S)-5-(4-fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino]({4-[(trimethylsilyl)oxy]phenyl})methyl]-5-[(trimethylsilyl)oxy]pentanoyl]-4-phenyl-1,3-oxazolidin-2-one

Conditions
ConditionsYield
Stage #1: chloro-trimethyl-silane; N-(4-hydroxybenzylidene)-4-fluorobenzenamine; (4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidine-2-one With N-ethyl-N,N-diisopropylamine In dichloromethane at -10 - 0℃; Inert atmosphere;
Stage #2: With titanium tetrachloride In dichloromethane at -30 - -25℃; Inert atmosphere;
66.6%
With triethylamine In dichloromethane at -20℃; Reagent/catalyst; Solvent;
chloro-trimethyl-silane
75-77-4

chloro-trimethyl-silane

N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

(4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidine-2-one
189028-95-3

(4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidine-2-one

C39H46F2N2O5Si2

C39H46F2N2O5Si2

Conditions
ConditionsYield
Stage #1: N-(4-hydroxybenzylidene)-4-fluorobenzenamine; (4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidine-2-one With N-ethyl-N,N-diisopropylamine In dichloromethane at -10 - -5℃;
Stage #2: chloro-trimethyl-silane In dichloromethane at -5℃; for 1.5h;
Stage #3: With N,O-bis-(trimethylsilyl)-acetamide; titanium tetrachloride more than 3 stages;
65%
N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

chloromethyl methyl ether
107-30-2

chloromethyl methyl ether

(4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidine-2-one
189028-95-3

(4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidine-2-one

C37H38F2N2O7

C37H38F2N2O7

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at -20 - -10℃; for 1h; Temperature; Reagent/catalyst;64.5%
chloro-trimethyl-silane
75-77-4

chloro-trimethyl-silane

N,O-bis-(trimethylsilyl)-acetamide
10416-59-8

N,O-bis-(trimethylsilyl)-acetamide

N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

(4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidine-2-one
189028-95-3

(4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidine-2-one

(4S)-3-[(2R,5S)-5-(4-fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino]({4-[(trimethylsilyl)oxy]phenyl})methyl]-5-[(trimethylsilyl)oxy]pentanoyl]-4-phenyl-1,3-oxazolidin-2-one
272778-12-8

(4S)-3-[(2R,5S)-5-(4-fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino]({4-[(trimethylsilyl)oxy]phenyl})methyl]-5-[(trimethylsilyl)oxy]pentanoyl]-4-phenyl-1,3-oxazolidin-2-one

Conditions
ConditionsYield
Stage #1: chloro-trimethyl-silane; N-(4-hydroxybenzylidene)-4-fluorobenzenamine; (4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidine-2-one With N-ethyl-N,N-diisopropylamine In dichloromethane at -10 - -5℃; for 1h;
Stage #2: With titanium tetrachloride In dichloromethane at -30℃; for 20h;
Stage #3: N,O-bis-(trimethylsilyl)-acetamide
60%
N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

m-nitrobenzoic acid chloride
121-90-4

m-nitrobenzoic acid chloride

C20H13FN2O4

C20H13FN2O4

Conditions
ConditionsYield
With dmap; triethylamine In dichloromethane at 20 - 30℃; Large scale;59%
(S)-3-(5-(4-fluorophenyl)-5,5-dimethoxypentanoyl)-4-phenyloxazolidin-2-one
1185883-41-3

(S)-3-(5-(4-fluorophenyl)-5,5-dimethoxypentanoyl)-4-phenyloxazolidin-2-one

N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

benzyl chloroformate
501-53-1

benzyl chloroformate

C41H34F2N2O7
1185883-42-4

C41H34F2N2O7

Conditions
ConditionsYield
Stage #1: N-(4-hydroxybenzylidene)-4-fluorobenzenamine; benzyl chloroformate With N-ethyl-N,N-diisopropylamine In dichloromethane; toluene at 0 - 20℃; for 1.66667h;
Stage #2: (S)-3-(5-(4-fluorophenyl)-5,5-dimethoxypentanoyl)-4-phenyloxazolidin-2-one With titanium(IV) trichloride isopropoxide In dichloromethane; toluene at -35 - -30℃; for 3.33333h;
51.76%
N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

stearic acid
57-11-4

stearic acid

C31H44FNO2

C31H44FNO2

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In tetrahydrofuran for 6h;45%
N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

1-hexadecylcarboxylic acid
57-10-3

1-hexadecylcarboxylic acid

C29H40FNO2

C29H40FNO2

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In tetrahydrofuran for 6h;44%
lauric acid
143-07-7

lauric acid

N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

C25H32FNO2

C25H32FNO2

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In tetrahydrofuran for 6h;41%
N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

n-tetradecanoic acid
544-63-8

n-tetradecanoic acid

C27H36FNO2

C27H36FNO2

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In tetrahydrofuran for 6h;41%
1-decanoic acid
334-48-5

1-decanoic acid

N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

C23H28FNO2

C23H28FNO2

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In tetrahydrofuran for 6h;38%
N-(2-chloroethyl)-pyrrolidine
5050-41-9

N-(2-chloroethyl)-pyrrolidine

N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

4-fluorophenyl[4-(2-pyrrolidin-1-yl-ethoxy)benzylidene]amine

4-fluorophenyl[4-(2-pyrrolidin-1-yl-ethoxy)benzylidene]amine

Conditions
ConditionsYield
Stage #1: N-(4-hydroxybenzylidene)-4-fluorobenzenamine With potassium carbonate In acetone for 0.166667h; Inert atmosphere;
Stage #2: N-(2-chloroethyl)-pyrrolidine In acetone Inert atmosphere; Reflux;
37%
3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-2-oxazolidinone

3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-2-oxazolidinone

N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

C39H47FN2O4Si2

C39H47FN2O4Si2

Conditions
ConditionsYield
Stage #1: 3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-2-oxazolidinone; N-(4-hydroxybenzylidene)-4-fluorobenzenamine With chloro-trimethyl-silane; N-ethyl-N,N-diisopropylamine; titanium tetrachloride In n-heptane; toluene at -35 - -10℃; for 4.75h;
Stage #2: With bistrimethylsilylacetamide In n-heptane; toluene for 0.5h; Heating / reflux;
(S)-3-{4-[2-(4-fluorophenyl)dioxolan-2-yl]butanoyl}-4-phenyl-oxazolidin-2-one
942485-56-5

(S)-3-{4-[2-(4-fluorophenyl)dioxolan-2-yl]butanoyl}-4-phenyl-oxazolidin-2-one

N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

(S)-3-{(R)-2-[(S)-(4-fluorophenylamino)-(4-hydroxyphenyl)methyl]-4-[2-(4-fluorophenyl)-[1,3]-dioxolan-2-yl]butyryl}-4-phenyloxazolidin-2-one
954109-25-2

(S)-3-{(R)-2-[(S)-(4-fluorophenylamino)-(4-hydroxyphenyl)methyl]-4-[2-(4-fluorophenyl)-[1,3]-dioxolan-2-yl]butyryl}-4-phenyloxazolidin-2-one

Conditions
ConditionsYield
Stage #1: (S)-3-{4-[2-(4-fluorophenyl)dioxolan-2-yl]butanoyl}-4-phenyl-oxazolidin-2-one; N-(4-hydroxybenzylidene)-4-fluorobenzenamine With chloro-trimethyl-silane; N-ethyl-N,N-diisopropylamine In dichloromethane at -10℃; for 1.5h;
Stage #2: With titanium tetrachloride In dichloromethane at -15℃;
N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

benzyl chloroformate
501-53-1

benzyl chloroformate

benzyl-[4-(4-fluorophenyliminomethyl)phenyl]-carbonate
1159183-27-3

benzyl-[4-(4-fluorophenyliminomethyl)phenyl]-carbonate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane; toluene at 5 - 10℃;
With N-ethyl-N,N-diisopropylamine In dichloromethane; toluene at 5 - 10℃; for 1.08333h;
Reaxys ID: 19845321

Reaxys ID: 19845321

N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

Reaxys ID: 19845322

Reaxys ID: 19845322

Reaxys ID: 19845323

Reaxys ID: 19845323

N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

(4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidine-2-one
189028-95-3

(4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidine-2-one

Reaxys ID: 19845322

Reaxys ID: 19845322

Conditions
ConditionsYield
With titanium tetrachloride; N-ethyl-N,N-diisopropylamine In dichloromethane
(S)-3-(5-(4-fluorophenyl)-5-(hydroxyimino)pentanoyl)-4-phenyloxazolidin-2-one

(S)-3-(5-(4-fluorophenyl)-5-(hydroxyimino)pentanoyl)-4-phenyloxazolidin-2-one

N-(4-hydroxybenzylidene)-4-fluorobenzenamine
3382-63-6

N-(4-hydroxybenzylidene)-4-fluorobenzenamine

C39H45F2N3O5Si2

C39H45F2N3O5Si2

Conditions
ConditionsYield
Stage #1: (S)-3-(5-(4-fluorophenyl)-5-(hydroxyimino)pentanoyl)-4-phenyloxazolidin-2-one; N-(4-hydroxybenzylidene)-4-fluorobenzenamine With chloro-trimethyl-silane; N-ethyl-N,N-diisopropylamine In dichloromethane at -10 - -5℃;
Stage #2: titanium tetrachloride In dichloromethane at -30 - -25℃; for 3 - 6h;

3382-63-6Relevant articles and documents

A New Pathway for Protein Haptenation by β-Lactams

Pérez-Ruíz, Raúl,Lence, Emilio,Andreu, Inmaculada,Limones-Herrero, Daniel,González-Bello, Concepción,Miranda, Miguel A.,Jiménez, M. Consuelo

, p. 13986 - 13994 (2017)

The covalent binding of β-lactams to proteins upon photochemical activation has been demonstrated by using an integrated approach that combines photochemical, proteomic and computational studies, selecting human serum albumin (HSA) as a target protein and ezetimibe (1) as a probe. The results have revealed a novel protein haptenation pathway for this family of drugs that is an alternative to the known nucleophilic ring opening of β-lactams by the free amino group of lysine residues. Thus, photochemical ring splitting of the β-lactam ring, following a formal retro-Staudinger reaction, gives a highly reactive ketene intermediate that is trapped by the neighbouring lysine residues, leading to an amide adduct. For the investigated 1/HSA system, covalent modification of residues Lys414 and Lys525, which are located in sub-domains IIIA and IIIB, respectively, occurs. The observed photobinding may constitute the key step in the sequence of events leading to photoallergy. Docking and molecular dynamics simulation studies provide an insight into the molecular basis of the selectivity of 1 for these HSA sub-domains and the covalent modification mechanism. Computational studies also reveal positive cooperative binding of sub-domain IIIB that explains the experimentally observed modification of Lys414, which is located in a barely accessible pocket (sub-domain IIIA).

Mesomorphic properties and X-ray diffraction studies of 4-alkanoyloxybenzylidene-4′-fluoroaniline

Ha, Sie-Tiong,Lee, Teck-Leong,Lee, Siew-Ling,Yeap, Guan-Yeow,Lin, Hong-Cheu,Ito, Masato M.

, p. 7737 - 7740 (2014)

A new homologous series of Schiff base esters comprising a terminal fluoro substituent was studied. Molecular polarizability is enhanced by the presence of fluoro substituent, subsequently, affecting intermolecular interactions and resulting in smectic molecular arrangement. All members can be differed from the number of carbons at the alkanoyloxy chain (Cn-1H2n-1COO-, n = 10, 12, 14, 16, 18). The structure of the title compound was confirmed by spectroscopic (IR and NMR) techniques along with mass spectrometric analysis. Their mesomorphic properties were studied by using differential scanning calorimetry and optical polarizing microscopy techniques. Early members (n = 10, 12 and 14) exhibited monotropic smectic A phase while the longer chain members (n = 16 and 18) are non mesogenic compounds. X-ray diffraction analysis was used and confirmed monolayer of smectic A phase in n-dodecanoyloxy derivative.

Additional effect of para-hydroxyl on the reduction potentials of the N-benzylidenebenzenamines

Cao, Chao-Tun,Zhou, Wei,Cao, Chenzhong

, (2019/12/27)

The reduction potential ERed of disubstituted N-benzylidenebenzenamines XArCH NArY (abbreviated as XBAY) is a measure of the electron acceptance ability of the Lowest-energy Unoccupied Molecular Orbital (LUMO) in molecule, which is closely related to the electronic effects of substituents X and Y in molecule. Previous studies on the ERed of XBAY reported by Luo, Wang, and Yuan all did not involve these molecules containing hydroxyl. In this work, 28 samples of disubstituted N-benzylidenebenzenamines containing para-hydroxyl, (abbreviated as 4-OHBAY or XBAOH-4′) were synthesized, and their ERed values were measured. Then, 127 compounds were taken as a complicated ERed data set, which involved 28 compounds (4-OHBAY and XBAOH-4′) of this work and 99 compounds XBAY reported by Luo. Based on these data ERed set, through a quantitative regression analysis method and comparison of the factors affecting the ERed, the following results are obtained: (a) Because the phenolic hydroxyl OH can dissociate H+ to form phenolic oxygen anion, the change regularity of ERed of compounds 4-OHBAY and XBAOH-4′ is somewhat different from that of ERed of XBAY compounds without hydroxyl OH. That is, hydroxyl OH has an additional effect on the ERed, which decreases the ERed value. (b) The additional effects of 4-OH on the ERed is different from that of 4′-OH. The effect of hydroxyl OH attached to the aldehyde aromatic ring on the ERed is more than that of OH attached to the amine aromatic ring.

Iron-Catalyzed Nitrene Transfer Reaction of 4-Hydroxystilbenes with Aryl Azides: Synthesis of Imines via C=C Bond Cleavage

Peng, Yi,Fan, Yan-Hui,Li, Si-Yuan,Li, Bin,Xue, Jing,Deng, Qing-Hai

, p. 8389 - 8394 (2019/10/16)

C=C bond breaking to access the C=N bond remains an underdeveloped area. A new protocol for C=C bond cleavage of alkenes under nonoxidative conditions to produce imines via an iron-catalyzed nitrene transfer reaction of 4-hydroxystilbenes with aryl azides is reported. The success of various sequential one-pot reactions reveals that the good compatibility of this method makes it very attractive for synthetic applications. On the basis of experimental observations, a plausible reaction mechanism is also proposed.

Effect of substituents on the UV spectra of supermolecular system: Silver nanoparticles with bi-aryl Schiff bases containing hydroxyl

Cao, Chao-Tun,Cheng, Shimao,Zhang, Jingyuan,Cao, Chenzhong

, (2018/11/25)

Effect of substituents on the ultraviolet (UV) spectra of supermolecular system involving silver nanoparticles (AgNPs) and Schiff bases was investigated. AgNPs and 49 samples of model compounds (MC), bi-aryl Schiff bases containing hydroxyl (XBAY, involving 4-OHArCH?NArY, 2-OHArCH?NArY, XArCH?NAr-4′-OH, and XArCH?NAr-2′-OH), were synthesized. The size of AgNPs was characterized by transmission electron microscopy (TEM), and the UV absorption spectra of AgNPs, XBAYs, and MC-AgNPs mixed solutions were measured, respectively. The results show that (1) the size of AgNPs is larger in MC-AgNPs solutions than that in AgNPs solution due to the distribution of MC molecules on the surface of AgNPs; (2) the UV absorption wavelength of XBAYs changes in the action of AgNPs and their wavelength shift exists limitation between XBAY and MC-AgNPs solutions; and (3) the wavelength shift limit of MC-AgNPs (λWSL) is influenced by the substituents X and Y and the position of hydroxyl OH. The wavenumber ΔνWSL of λWSL can be quantified by employing the excited-state substituent constant σexCC and Hammett constant σ of substituents X and Y. Comparing with the 4-OH, the 4′-OH makes the ΔνWSL a red shift, whereas the 2′-OH, comparing with the 2-OH, makes the ΔνWSL a blue shift.

Production method of Ezetimibe intermediate

-

Paragraph 0029; 0030; 0031, (2017/08/29)

The invention discloses a two-stage three-step method for preparing an Ezetimibe intermediate. The method comprises the following steps: stage one, using common commodities such as p-hydroxy benzaldehyde and p-fluoro aniline as reactants and using water as a reagent, and carrying out heating condensation to generate Schiff base, wherein the yield can reach 97.0%; and stage two, the stage comprising two steps, firstly using a chiral reducing reagent R-CBS and borane dimethyl sulfide to reduce a starting material 1 and obtain an in situ intermediate; enabling the in situ intermediate to directly react with the Schiff base obtained in the stage one, so as to obtain the final product Ezetimibe intermediate, wherein the yield can reach more than 75.0%. In the first step of the second stage, a sulfuric acid solution, a 5% sodium sulfite solution and a 10% sodium chloride solution are used in sequence for washing an organic phase, and finally the organic phase is washed with water and is dried by using sodium sulfate, so that various organic and inorganic impurities are sufficiently removed, and the in situ intermediate is not separated, but the purity is high. The prepared in situ intermediate reacts with the Schiff base, so that the Ezetimibe intermediate is high in yield and high in purity.

METHOD FOR PREPARING AZETIDINONE COMPOUND AND INTERMEDIATE OF AZETIDINONE COMPOUND

-

Paragraph 0054-0056, (2017/05/31)

Disclosed is a new method for preparing an azetidinone compound represented by formula (I). The carboxylic ketoester represented by formula (II) serves as the raw material and is subjected to Grignard addition, stereoselective dehydration, ester group reduction, hydroxyl group protection, addition with imine after condensation with a chiral auxiliary, cyclization and deprotection to obtain the compound represented by formula (I). The present invention has advantages of easily available raw material, a few synthetic steps, simple operation, high yield, good stereoselectivity and low cost, and can be used for industrial production.

according to folds Mai Bu and its intermediate synthesis method

-

Paragraph 0047; 0048; 0049, (2017/07/26)

The invention provides an Ezetimibe synthesis method comprising the following steps: (a) a compound (5) is subjected to asymmetric reduction reaction to obtain a compound (6), and the compound (6) and tert-butyldimethylsilyl chloride react in an organic solution under the action of alkali to obtain a compound (7); (b) the compound (7) and diisopropylethylamine are dissolved in the organic solution, titanium tetrachloride is added in the organic solution to react at 20-50 DEG C, and a compound (3) is added in the organic solution at minus 20 to minus 60 DEG C to react to obtain a compound (8); (c) the compound (8) and N,O-bis(trimethylsilyl) acetamide react in the organic solution at 20-80 DEG C, tetrabutylammonium fluoride trihydrate is added into the organic solution to react at 20-80 DEG C to obtain a compound (9); (d) the compound (9) is subjected to off-protection reaction to obtain Ezetimibe, wherein R is equal to TBS, Ac or COOCH2CCl3. The invention further provides an Ezetimibe intermediate and a preparation method thereof.

Abnormal effect of hydroxyl on the longest wavelength maximum in ultraviolet absorption spectra for bis-aryl Schiff bases

Cao, Chao-Tun,Zhou, Wei,Cao, Chenzhong

, (2017/09/19)

Two sets of bis-aryl Schiff bases that contain 4(or 4′)-OH and 2(or 2′)-OH were synthesized. The first set consists of 4-HOArCH=NArY and XArCH=NArOH-4′, and the second set consists of 2-HOArCH=NArY and XArCH=NArOH-2′. Their ultraviolet absorption spectra were measured and investigated. A very interesting phenomenon was observed by analyzing their wave number νmax (cm?1) of longest wavelength maximum λmax (nm) of ultraviolet. Compared with the change regularity of the νmax of XArCH=NArY (where the X and Y excluded OH), the 4′-position hydroxyl (4′-OH) and 2′-position hydroxyl (2′-OH) have abnormal performance. The details are the following: the 4′-OH contributes an additional red shift to the νmax of XArCH=NArOH-4′ (λmax increase), whereas the 2′-OH contributes an additional blue shift to the νmax of XArCH=NArOH-2′ (λmax decrease). In addition, there are ortho steric effects of all 2-OH and 2′-OH on the νmax for 2-HOArCH=NArY and XArCH=NArOH-2′, and the ortho steric effect contributes a red shift to their νmax. These experimental facts can provide an important theoretical reference for us using aryl Schiff base compounds as optical materials and performing the molecular design.

The evaluation of the role of C-H?F hydrogen bonds in crystal altering the packing modes in the presence of strong hydrogen bond

Kaur, Gurpreet,Singh, Sandhya,Sreekumar, Amritha,Choudhury, Angshuman Roy

, p. 154 - 169 (2015/11/18)

Interactions involving fluorine is an area of contemporary research. To unravel the importance of weak C-H?F hydrogen bonds and C-H?π interactions in organic compounds in the presence of strong hydrogen bond, a series of N-benzylideneanilines with simultaneously hydroxyl (-OH) and fluorine substitutions were synthesized for structural analysis. These compounds have been studied through experimental single crystal X-ray diffraction analysis and computational methods (Gaussian09 and AIM2000). The hydroxyl group present in all the molecules were found to form strong O-H?N hydrogen bond, but the spatial arrangement of the molecules connected by this hydrogen bond have been found to be controlled by the weak C-H?F and C-H?O hydrogen bonds, weak C-H?π and π?π interactions. This manuscript illustrates the importance of several weaker interactions in altering the packing modes in the presence of strong hydrogen bonds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 3382-63-6